Nadia Califaretti

1.8k total citations
23 papers, 250 citations indexed

About

Nadia Califaretti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nadia Califaretti has authored 23 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Nadia Califaretti's work include Advanced Breast Cancer Therapies (10 papers), Breast Cancer Treatment Studies (6 papers) and Cancer Treatment and Pharmacology (5 papers). Nadia Califaretti is often cited by papers focused on Advanced Breast Cancer Therapies (10 papers), Breast Cancer Treatment Studies (6 papers) and Cancer Treatment and Pharmacology (5 papers). Nadia Califaretti collaborates with scholars based in Canada, United States and France. Nadia Califaretti's co-authors include Stephen Chia, Daniel Rayson, Anil A. Joy, Susan Dent, Matthew W. Gorr, Jean-Pierre Ayoub, Sean Hopkins, Sanjiv K. Gandhi, Mark Clemons and Joel A. Dubin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Nadia Califaretti

22 papers receiving 244 citations

Peers

Countries citing papers authored by Nadia Califaretti

Since Specialization

Citations

This map shows the geographic impact of Nadia Califaretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Califaretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Califaretti more than expected).

Fields of papers citing papers by Nadia Califaretti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Califaretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Califaretti. The network helps show where Nadia Califaretti may publish in the future.

Co-authorship network of co-authors of Nadia Califaretti

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Califaretti. A scholar is included among the top collaborators of Nadia Califaretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Califaretti. Nadia Califaretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A systematic review on the management of ductal carcinoma in situ of the breast 2025 ·Surgical Oncology ·Muriel Brackstone, (unknown), Christine Koch, Nadia Califaretti, Andrea Eisen, (unknown), (unknown), Asad Salim	2
2	A Canadian real-world, multi-center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2-negative advanced breast cancer 2025 ·Breast Cancer Research and Treatment ·Catherine Doyle, Ana Elisa Lohmann, Nayyer Iqbal, Jan‐Willem Henning, Swati Kulkarni, Nadia Califaretti, John Hilton, Cristiano Ferrario, Nathaniel Bouganim, Mihaela Mates, (unknown), (unknown), Marc‐André Caron, (unknown), (unknown), Stephen Chia	1
3	Management of Ductal Carcinoma In Situ: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline 2024 ·Current Oncology ·Muriel Brackstone, (unknown), Nadia Califaretti, Andrea Eisen, (unknown), Asad Salim, (unknown), Christine Koch	0
4	Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study 2024 ·Current Oncology ·Arif Awan, Deanna Saunders, Gregory R. Pond, Caroline Hamm, Nadia Califaretti, Mihaela Mates, (unknown), Mohammed Ibrahim, (unknown), Lisa Vandermeer, John Hilton, Mark Clemons	2
5	126P A randomized controlled trial (RCT) comparing optimal local treatment with or without endocrine therapy (ET) in patients (pts) aged ≥70 with lower risk breast cancer (BC) [REaCT-70 Study] 2024 ·ESMO Open ·(unknown), (unknown), (unknown), (unknown), Adnan Bashir, Nadia Califaretti, (unknown), (unknown), Gregory R. Pond, Fiona MacDonald, (unknown), Isidro Machado, Lisa Clemons, Brian Hutton, Kednapa Thavorn, (unknown)	1
6	326P Exploratory analysis of TreatER+ight: A Canadian prospective real-world observational study in HR+ advanced breast cancer 2020 ·Annals of Oncology ·C. T. Doyle, Theodore A. Vandenberg, Cristiano Ferrario, Nadia Califaretti, Nayyer Iqbal, Swati Kulkarni, Mihaela Mates, John Hilton, Nathaniel Bouganim, (unknown), Sina Haftchenary, (unknown), Stephen Chia	1
7	Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT) 2019 ·Breast Cancer Research and Treatment ·(unknown), Arif Awan, Dean Fergusson, Lisa Vandermeer, Angel Arnaout, John Hilton, Brian Hutton, Anil A. Joy, Andrew Robinson, Nadia Califaretti, Carol Stober, (unknown), Kednapa Thavorn, Mark Clemons	19
8	Ribociclib (RIB) + letrozole (LET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) and central nervous system (CNS) metastases: Subgroup analysis from the phase IIIb CompLEEment-1 trial 2019 ·Annals of Oncology ·Paul Cottu, Michelino De Laurentiis, Paolo Marchetti, (unknown), Nadia Califaretti, Marc Debled, Shekhar Patil, Ella Evron, François P. Duhoux, (unknown), (unknown), (unknown), Javier Salvador Bofill	4
9	Real World Treatment Sequencing Outcomes of Endocrine-Based Targeted Combination Therapies in HR+ HER2- Advanced Breast Cancer 2018 ·European Journal of Cancer ·(unknown), C. Doyle, Nayyer Iqbal, Susan Dent, Cristiano Ferrario, (unknown), Nadia Califaretti	1
10	A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer 2017 ·Breast Cancer Research and Treatment ·Mohammed Ibrahim, John Hilton, Sasha Mazzarello, Dean Fergusson, Brian Hutton, Andrew Robinson, Nadia Califaretti, Tina Hsu, S. Gertler, Mihaela Mates, Carol Stober, Lisa Vandermeer, Ranjeeta Mallick, Mark Clemons	7
11	Abstract PR03: Molecular profiling of advanced solid tumors at Princess Margaret Cancer Centre and patient outcomes with genotype-matched clinical trials 2016 ·Clinical Cancer Research ·Philippe L. Bédard, Amit M. Oza, Blaise Clarke, Ming‐Sound Tsao, Natasha B. Leighl, Eric X. Chen, Albiruni R. Abdul Razak, Hal K. Berman, Stefano Serra, Michael H. A. Roehrl, Nadia Califaretti, Mateya Trinkaus, Tong Zhang, Mahadeo A. Sukhai, Anca Milea, Aaron R. Hansen, Trevor J. Pugh, Tracy Stockley, Suzanne Kamel‐Reid, Lillian L. Siu	5
12	Treat ER⁺ight: Treatment of Canadian postmenopausal women with ER⁺ HER2^- advanced breast cancer in the real-world setting with hormone therapy ± targeted therapy. 2016 ·Journal of Clinical Oncology ·Nadia Califaretti, Nathaniel Bouganim, Susan Dent, Catherine Doyle, Jan‐Willem Henning, John S. Sampalis, (unknown), Stephen Chia	1
13	Physician Preferences for Bone Metastasis Drug Therapy in Canada 2015 ·Current Oncology ·José-Luís Pérez-Arellano, Juan Marcos González, Yi Qian, (unknown), Ateesha F. Mohamed, Francesca Gatta, Brett Hauber, Joshua Posner, Nadia Califaretti, Edward Chow	9
14	Novel Agents and Associated Toxicities of Inhibitors of the PI3K/Akt/mTOR Pathway for the Treatment of Breast Cancer 2015 ·Current Oncology ·Stephen Chia, Sanjiv K. Gandhi, Anil A. Joy, (unknown), Matthew W. Gorr, Sean Hopkins, (unknown), Jean-Pierre Ayoub, Nadia Califaretti, Daniel Rayson, Susan Dent	93
15	Plasma amino acid profiles of breast cancer patients early in the trajectory of the disease differ from healthy comparison groups 2014 ·Applied Physiology Nutrition and Metabolism ·(unknown), Kirsten E. Bell, (unknown), Vivienne Vance, Rhona M. Hanning, (unknown), Joel A. Dubin, (unknown), Nadia Califaretti, Carolyn Campbell, Marina Mourtzakis	22
16	Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study 2014 ·Breast Cancer Research and Treatment ·Mark Clemons, (unknown), Gregory R. Pond, Nadia Califaretti, Stephen Chia, Rebecca Dent, Xinni Song, André Robidoux, Sameer Parpia, David Warr, Daniel Rayson, Kathleen I. Pritchard, Mark N. Levine	34
17	A comprehensive metabolic evaluation reveals impaired glucose metabolism and dyslipidemia in breast cancer patients early in the disease trajectory 2013 ·Clinical Nutrition ·Kirsten E. Bell, Katie M. Di Sebastiano, Vivienne Vance, Rhona M. Hanning, Andrew Mitchell, Joe Quadrilatero, (unknown), Joel A. Dubin, (unknown), Nadia Califaretti, Carolyn Campbell, Marina Mourtzakis	28
18	Randomized phase II placebo-controlled trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone receptor-positive metastatic breast cancer (MBC): OCOG Zamboney study—NCT00811369. 2013 ·Journal of Clinical Oncology ·Mark Clemons, (unknown), Nadia Califaretti, Stephen Chia, Rebecca Dent, Xinni Song, André Robidoux, Gregory R. Pond, Sameer Parpia, Kathleen I. Pritchard, Mark N. Levine	2
19	Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia 2004 ·Bone Marrow Transplantation ·Peter Mollee, Vikas Gupta, Kevin Song, (unknown), Nadia Califaretti, Richard Tsang, Michael Crump, Armand Keating	12
20	Tracheobronchial Constriction in Asthmatics Induced by Isocapnic Hyperventilation With Dry Cold Air 1996 ·CHEST Journal ·Gabriel Juliá-Serdà, Néstor A. Molfino, Nadia Califaretti, V. Hoffstein, Noé Zamel	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact